In breast cancer, MSC-derived exosomes induce a significant and dose-dependent decrease in the expression and secretion of VEGF through the modulation of the mTOR/HIF-1α signaling axis, suggesting an important potential therapeutic target for this type of tumor (Pakravan et al., 2017). The gene discussed is HIF1A; the disease is neoplasm.